Deep Track Capital, LP - Aug 12, 2025 SCHEDULE 13G Report for X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (XFOR)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
XFOR
Shares outstanding
23.7M shares
Disclosed Ownership
2.37M shares
Ownership
9.99%
Form type
SCHEDULE 13G
Date filed
8/19/2025, 04:05 PM
Date of event
Aug 12, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 9.99% 2.37M 0 2.37M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 9.99% 2.37M 0 2.37M /s/ David Kroin David Kroin, Director
David Kroin 9.99% 2.37M 0 2.37M /s/ David Kroin David Kroin